SYNthesis

SYNthesis, as a preclinical small molecule new drug research and development service company, mainly provides high-end medicinal chemistry and synthetic chemistry services to customers. Its headquarters is located in Hong Kong, with service platforms in Suzhou, Shanghai, and Australia. SYNthesis's customer revenue mainly comes from the United States, Australia, and the United Kingdom, and the company has branches in these regions for project management and business development. The company’s senior scientific management team consists of several international professionals with extensive experience in drug development. As of December 31, 2019, the company had more than 200 employees and has provided services to over 250 pharmaceutical and biotech companies worldwide.